Opendata, web and dolomites


Development of hybrid artificial skin substitute for chronic diabetic wounds

Total Cost €


EC-Contrib. €






 SKIN SUBSTITUTE project word cloud

Explore the words cloud of the SKIN SUBSTITUTE project. It provides you a very rough idea of what is the project "SKIN SUBSTITUTE" about.

validate    combines    property    vivo    models    network    leadership    techniques    malignancies    people    garcia    reg    scaffold    gold    biology    rabbit    substitute    million    interventions    medical    antimicrobial    antibacterial    components    functionalized    evaluation    fibroblast    alloderm    complementary    healing    skills    68    therapeutic    secondment    clinical    fda    foot    international    discipline    motivation    position    cell    hmsc    ago    papy    pandit    leveraging    standards    translate    intellectual    efficacy    controls    strategies    affairs    time    me    15    maturity    vitro    diabetic    amputation    biopolymer    skin    goals    collaborative    requiring    ulcer    dulce    compatibility    regulatory    training    histological    benefit    acting    progress    it    clinic    zno    stereological    approved    alloxan    trial    worse    first    transferable    24    diversity    prof    independence    dfu    43    diabetes    polymer    completion    group    establishing    communication    culture    molecular    patients    career    commercial    strategy    cellular    mortality    2030    professional    innovative    incorporating    exchequer    plan    grafts    bioactive    setting    integra    synthetic    wound    incidence    hybrid    keratinocyte    device    reimbursement    3d    agents    nanoparticles    14    model   

Project "SKIN SUBSTITUTE" data sheet

The following table provides information about the project.


Organization address
city: Galway
postcode: H91

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 187˙866 €
 EC max contribution 187˙866 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2020-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NATIONAL UNIVERSITY OF IRELAND GALWAY IE (Galway) coordinator 187˙866.00


 Project objective

It is estimated that the incidence of diabetes in Europe will affect 43 million people by 2030. 15% of diabetic patients develop a diabetic foot ulcer (DFU) with 14-24% of these patients requiring amputation. Mortality following amputation of 50–68% is comparable or worse than for most malignancies. My strategy will develop for the first time a skin substitute which combines a biopolymer and a functionalized synthetic FDA approved polymer incorporating bioactive components and AgO and ZnO nanoparticles as antibacterial agents. The cellular compatibility of the hybrid skin substitute will be assessed on fibroblast, keratinocyte and hMSC in a 3D cell culture model. The antimicrobial efficacy will be assessed in vitro and in vivo. The optimised scaffold will be assessed in an alloxan-induced diabetic rabbit ulcer model with gold standards Integra® and Alloderm® skin grafts acting as commercial controls to validate the commercial potential of the technology. Progress to completion will be reviewed by a Research and Professional Development Plan which will provide both discipline-specific and complementary technical training (molecular biology, diabetic wound healing in vivo models, and histological and stereological techniques) and generic and complementary transferable skills training (e.g. intellectual property, leadership skills, motivation skills, communication skills, leveraging non-exchequer funding, regulatory affairs, clinical trial design, reimbursement strategies, medical device evaluation and regulatory affairs). I will benefit from Prof Pandit’s and Prof Dulce Papy-Garcia (secondment) international collaborative network in the field of diabetic wound healing. This training will facilitate me to achieve my future career goals of achieving a position of professional maturity, diversity and independence by establishing my own research group at a leading European institution and enabling me to translate innovative therapeutic interventions to the clinic setting.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKIN SUBSTITUTE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SKIN SUBSTITUTE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NPsVLCD (2019)

Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease

Read More  

MIGPSC (2018)

Shaping the European Migration Policy: the role of the security industry

Read More  


A multilinear approach to the restriction problem with applications to geometric measure theory, the Schrödinger equation and inverse problems

Read More